Massive gene studies are letting biotechnology companies learn from nature, and imitate it.
The $121 million National Microbiome Initiative is meant to spur investigation into the mysterious functions of the micro?rganisms inside us.
It sounds crazy, and it is. A startup says it can use genetic engineering to change the color of animal coats.
An experimental treatment helps diabetic mice grow new blood vessels. It could offer new hope to people with vascular disease.
A gene therapy for an inherited immune disease completes a 27-year journey.
Millions more could be exposed to the virus by 2018, the earliest a vaccine will be ready.
A new test uses synthetic biology to detect Zika with a high level of specificity.
There’s a chance to use cutting-edge technology to save native Hawaiian birds from the mosquitoes that are driving them to extinction.
Spider silk has the ability to resolve features smaller than any ordinary microscope can see, say materials scientists.
AbbVie’s purchase of the cancer fighting startup backed by Peter Thiel’s Founders Fund bodes well for biotech funding.